Skip to main content
Hanmi Science Co.,Ltd logo

Hanmi Science Co.,Ltd — Investor Relations & Filings

Ticker · 008930 ISIN · KR7008930000 KO Manufacturing
Open in API
Filings indexed 698 across all filing types
Latest filing 2026-03-20 Annual Report
Country KR South Korea
Listing KO 008930

About Hanmi Science Co.,Ltd

https://www.hanmipharm.com/

Hanmi Science Co., Ltd. is a holding company that manages subsidiaries engaged in the pharmaceutical and healthcare sectors. Its principal operating subsidiary, Hanmi Pharmaceutical, is an R&D-centric biopharmaceutical company focused on the development of innovative new drugs. The group's integrated activities span from in-house research and development to the manufacturing and commercialization of a wide range of pharmaceutical products. A key strategic focus is the creation of novel therapies to address unmet medical needs, which are then provided to medical professionals.

Recent filings

Filing Released Lang Actions
사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for Hanmi Science Co., Ltd. for the 53rd fiscal year (2025). It contains comprehensive financial data, company history, management information, capital structure, and business operations. In the South Korean regulatory context, the 'Business Report' (사업보고서) is the equivalent of the US 10-K annual report, as it is the primary annual disclosure document filed with the Financial Supervisory Service (FSS) and the Korea Exchange (KRX). FY 2025
2026-03-20 Korean
감사보고서제출(자회사의 주요경영사항)
Audit Report / Information Classification · 98% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) titled 'Audit Report Submission' (감사보고서 제출). It provides the audit opinion (unqualified/proper), key financial data (assets, liabilities, equity, revenue, profit), and details regarding the external auditor. While it contains financial data, it is a standardized regulatory disclosure form used in the Korean market to announce the receipt and filing of the audit report, rather than the full annual report document itself. Therefore, it is classified as a regulatory filing. FY 2025
2026-03-18 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) titled '감사보고서 제출' (Submission of Audit Report). It contains the auditor's opinion, financial statements (consolidated and separate), and key financial metrics for the fiscal year. While it provides financial data, it is a specific regulatory disclosure of the audit results rather than a full Annual Report (10-K) or a simple announcement of a report's availability (RPA). In the context of the provided categories, 'AR' (Audit Report / Information) is the most accurate classification for standalone audit report filings. FY 2025
2026-03-18 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (Korea). This is a standard regulatory filing used to disclose insider trading or changes in share ownership by company directors and executives. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS).
2026-03-18 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 95% confidence The document is a 'Report of Change in Shareholding by Major Shareholders and Related Parties' (최대주주등소유주식변동신고서) for Hanmi Science. It details specific transactions (buy/sell) by company executives and major shareholders, including names, dates, and the number of shares changed. This falls under the category of 'Director's Dealing' (DIRS) as it reports personal share transactions by company directors and executives, or alternatively 'Major Shareholding Notification' (MRQ) if it were a threshold crossing. Given the focus on individual executive transactions (e.g., Kim Jae-gyo), 'DIRS' is the most accurate classification.
2026-03-18 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Hanmi Science Co., Ltd. It contains the meeting agenda, voting procedures, director activity reports, and management information. This type of document is a formal proxy statement and information package sent to shareholders to solicit votes for an upcoming Annual General Meeting (AGM). In the provided taxonomy, 'Proxy Solicitation & Information Statement' (PSI) is the most accurate classification for a document that provides meeting details, agenda items, and proxy voting instructions.
2026-03-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.